The Association between Psycho-Socio-Demographic Factors and Substance Abuse in Iranian Male Bodybuilders
American Journal of Sports Science
Volume 3, Issue 1, January 2015, Pages: 13-17
Received: Dec. 6, 2014; Accepted: Dec. 23, 2014; Published: Feb. 2, 2015
Views 2932      Downloads 231
Authors
Hooman Angoorani, Assistant Professor of Sports Medicine, Department of Sports and Exercise Medicine, Hazrat Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, IR Iran
Behnoosh Tayyebi, Faculty Member of Islamic Azad University, Tehran North Branch, Tehran, Iran
Article Tools
Follow on us
Abstract
Background: This study was conducted to investigate the association between psycho-socio-demographic factors and substance abuse in Iranian male bodybuilders. Material and methods: 906 male bodybuilders from 103 randomly selected gymnasia in Tehran participated in this research. By interviews via questionnaires, the following data over age, employment, average monthly family income, family size, gymnasium area (m2), number of trainers, number of gymnasium members, initiation time (months), weekly duration of sporting activity (hours), monthly cost of sporting activity, purpose of participating in sporting activity, mental health as well as body image (via General Health Questionnaire and Multidimensional Body-Self Relations Questionnaire, respectively), and history of substance abuse were collected. Results: All samples were male bodybuilders within the age range of 14 to 56 years (25/7+/-7/1). Substance abuse was reported in 140 (15/5%) of the subjects. Amphetamine was reported as the most commonly-used illicit drug (13/2%). Monthly family income, number of family members, enhancement of self-esteem, maintaining fitness, and satisfaction over body parts were associated with substance abuse. Conclusion: Some psycho-socio-demographic factors including family income, family size, enhancement of self-esteem, maintaining fitness, and satisfaction over body parts were associated with substance abuse among male bodybuilders.
Keywords
Substance, Drug, Abuse, Bodybuilders, Sport
To cite this article
Hooman Angoorani, Behnoosh Tayyebi, The Association between Psycho-Socio-Demographic Factors and Substance Abuse in Iranian Male Bodybuilders, American Journal of Sports Science. Vol. 3, No. 1, 2015, pp. 13-17. doi: 10.11648/j.ajss.20150301.13
References
[1]
Peretti-Watel P, Guagliardo V, Verger P, Pruvost J, Mignon P, Obadia Y. Sporting activity and drug use: Alcohol, cigarette and cannabis use among elite student athletes. Addiction 2003; 98: 1249-56.
[2]
McArdle. P, Wiegersma A, Gilvarry E, et al. International variations in youth drug use: the effect of individual behaviors, peer and family influences, and geographical location. Eur Addict Res 2000; 6: 163-9.
[3]
Pate RR, Trost SG, Levin S, Dowda M. Sports participation and health-related behaviors among US youth. Arch Pediatr Adolesc Med 2000; 154: 904-11.
[4]
Lorene FO, Peretti-Watel P, Grelot L. Cannabis use to enhance sportive and non-sportive performances among French sport students. Addict Behave 2005; 30: 1382-91.
[5]
Wagner JC. Abuse of drugs used to enhance athletic performance. Am J Hosp Pharm 1989; 46: 2059-67.
[6]
Challier B, Chau N, Predine R, Choquet M, Legras B. Associations of family environment and individual factors with tobacco, alcohol and illicit drug use in adolescents.Eur J Epidemiol 2000; 16: 33-42.
[7]
Margaria R, Aghemo P, Rovelli E. The effect of some drugs on the maximal capacity of athletic performance in man. Eur J Appl Physiol 1964; 20: 281-7.
[8]
The world anti doping code: The 2008 prohibited list, international standard. The world anti doping agent. Available at:http://www.wada-ama.org/rtecontent/ document/2008_List_En.pdf. Accessed 2 May 2008.
[9]
Clarkson PM, Thompson HS. Drugs and sport. Research findings and limitations. Sports Med 1997; 24: 366-84.
[10]
Laties VG, Weiss B. The amphetamine margin in sports. Fed Proc 1981; 40: 2689-92.
[11]
Toohey JV. Non-medical drug use among intercollegiate athletes at five American universities. Bulletin on Narcotics UNODC 1978; 3: 7.
[12]
Kanayama G, Pope HG, Jr, Hudson JI. ‘Body image’ drugs: a growing psychosomatic problem. Psychother Psychosom. 2001; 70:61–65.
[13]
Brennan BP, Kanayama G, Hudson JI, Pope HG., Jr Illicit human growth hormone abuse in male weightlifters.Addict Behav. 2011;20:9–13.
[14]
Hildebrandt T, Alfano L, Langenbucher JW. Body image disturbance in 1,000 male appearance- and performance-enhancing drug users. J Psychiatr Res. 2010; 44:841–846.
[15]
Angoorani H, Narenjiha H, Tayyebi B, et al. Amphetamine use and its associated factors in bodybuilders: a study from Tehran, Iran. Arch Med Sci.2012;8(2):362-367
[16]
Kanayama G, Hudson JI, Pope HG., Jr Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008; 98:1–12.
[17]
Pope HG, Jr, Katz DL. Psychiatric effects of exogenous anabolic-androgenic steroids. In: Wolkowitz OM, Rothschild AJ, editors. Psychoneuroendocrinology. The Scientific Basis of Clinical Practice. Washington: American Psychiatric Press; 2003. pp. 331–358.
[18]
Kanayama G, Brower KJ, Wood RI, et al. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009; 104:1966–1978.
[19]
Kanayama G, Brower KJ, Wood RI, et al. Treatment of anabolic-androgenic steroid dependence: emerging evidence and its implications. Drug Alcohol Depend. 2010;109:6–13.
[20]
Pope HG, Jr, Kean J, Nash A, Kanayama G, Samuel DB, Bickel WK, Hudson JI. A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity. Exp Clin Psychopharmacol. 2010;18:203–210
[21]
Pope HG, Kanayama G, Hudson JI. Risk Factors for Illicit Anabolic-Androgenic Steroid Use in Male Weightlifters: A Cross-Sectional Cohort Study. Biol Psychiatry. 2012;71(3):254–261.
[22]
Malakouti SK, Fatollahi P, Mirabzadeh A, Zandi T. Reliability, validity and factor structure of the GHQ-28 used among elderly Iranians. Int Psychogeriatr. 2007; 19(4):623-34.
[23]
Rahati A. Reliability and validity of the Multidimensional Body-Self Relations Questionnaire (MBSRQ) used among female adolescents in Iran. 2004; Master Thesis, Tehran University (not published)
[24]
Kashi A, Kargarfard M, Molavi H, Sarlak Z. ergogenic agents abuse among bodybuilders: prevalence and knowledge about the side effects. Olympic Journal. 2006;14:73-86 (Published in farsi)
[25]
Perry PJ, Lund BC, Deninger MJ, et al. Anabolic steroid use in weightlifters and bodybuilders: an Internet survey of drug utilization. Clin J Sport Med. 2005;15:326–30
[26]
Copeland J, Peters R, Dillon P. Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users. Drug Alcohol Depend. 2000; 60:91–6.
[27]
Striegel H, Simon P, Frisch S, et al. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend. 2006; 81:11–19.
[28]
Kanayama G, Hudson JI, Pope HG Jr. Features of men with anabolic-androgenic steroid dependence: a comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009; 102:130–7.
[29]
Matthew D, Jason M, Gomathi S. Predicting future anabolic-androgenic steroid use intentions with current substance use: findings from an internet-based survey. Clin J Sport Med. 2009;19(3):222-227
[30]
Santarnecchi E, Dèttore D. Muscle dysmorphia in different degrees of bodybuilding activities: validation of the Italian version of Muscle Dysmorphia Disorder Inventory and Bodybuilder Image Grid. Body Image. 2012;9(3):396-403.
[31]
Mosley PE. Bigorexia: bodybuilding and muscle dysmorphia. Eur Eat Disord Rev. 2009; 17(3):191-198.
[32]
Babusa B, Túry F. Muscle dysmorphia in Hungarian non-competitive male bodybuilders. Eat Weight Disord. 2012; 17(1):49-53.
[33]
Mangweth B, Pope HG Jr, Kemmler G, et al. Body image and psychopathology in male bodybuilders. Psychother Psychosom. 2001;70(1):38-43
[34]
Iversen L. Speed, ecstasy, ritalin: the science of amphetamines. Addiction 2007; 102: 1005-7.
[35]
Rawson RA, Gonzales R, McCann M, Ling W. Use of methamphetamine by young people: is there reason for concern? Addiction 2007; 102: 1021-2.
[36]
Hao W, Xiao S, Liu T, et al. The second National Epidemiological Survey on illicit drug use at six highprevalence areas in China: prevalence rates and use patterns. Addiction 2002; 97: 1305-15.
[37]
Degenhardt L, Coffey C, Moran P, Carlin JB, Patton GC. The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study. Addiction 2007; 102: 1076-84.
[38]
Feizzadeh A. Ecstasy: a new substance. Social Welfare 2002; 1: 105-16.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186